التفاصيل البيبلوغرافية
| العنوان: |
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. |
| المؤلفون: |
Palmerini, Tullio1, Biondi-Zoccai, Giuseppe2, Della Riva, Diego1, Stettler, Christoph3, Sangiorgi, Diego1, D'Ascenzo, Fabrizio4, Kimura, Takeshi5, Briguori, Carlo6, Sabatè, Manel7, Hyo-Soo Kim8, De Waha, Antoinette9, Kedhi, Elvin10, Smits, Pieter C.10, Kaiser, Christoph11, Sardella, Gennaro12, Marullo, Antonino2, Kirtane, Ajay J.13, Leon, Martin B.13, Stone, Gregg W.13 gs2184@cotumbia.edu |
| المصدر: |
Lancet. 4/14/2012, Vol. 379 Issue 9824, p1393-1402. 10p. |
| مصطلحات موضوعية: |
THROMBOSIS, DRUG-eluting stents, SURGICAL stents, COBALT, CHROMIUM, PLATINUM |
| مصطلحات جغرافية: |
UNITED States |
| الشركة/الكيان: |
UNITED States. Food & Drug Administration |
| مستخلص: |
The article presents a study which compares the risk of stent thrombosis between drug-eluting and bare-metal stents in the U.S. The study analyzes Food and Drug Administration (FDA)-approved stents such as cobalt-chromium everolimus-eluting stents (CoCr-EES), platinum-chromium EES (PtCr-EES) and phosphorylcholine-based zotarolimus-eluting stents (PC-ZES). It is found out that Co-Cr-EES shows that lowest rate of stent thrombosis after two years of implantation. |
| قاعدة البيانات: |
Business Source Index |
